Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Nov 15;54(3):289-94.
doi: 10.1007/BF00426578.

Pentazocine, cyclazocine, and nalorphine as discriminative stimuli

Pentazocine, cyclazocine, and nalorphine as discriminative stimuli

I D Hirschhorn. Psychopharmacology (Berl). .

Abstract

Pentazocine, cyclazocine, and nalorphine are narcotic antagonists that also have analgesic activity of their own. The present investigation compared the stimulus properties of these three drugs in rats. Each drug was used as a discriminative stimulus for a separate group of rats. Depression of one lever resulted in food reinforcement following the administration of drug, and the opposite lever was reinforced after saline. Each drug readily acquired control of discriminated responding. The specific narcotic antagonist, naloxone, which antagonizes many of the effects of pentazocine, cyclazocine, and nalorphine, also antagonized the discrimination of these drugs. Stimulus generalization tests to each other narcotic antagonist, d-amphetamine, morphine, and LSD, showed that each narcotic antagonist has highly specific stimulus properties. Clear generalization occurred only to pentazocine and cyclazocine in the nalorphine-saline group, but neither cyclazocine nor pentazocine generalized to nalorphine.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1970 May-Jun;11(3):385-403 - PubMed
    1. J Pharmacol Exp Ther. 1976 Jul;198(1):54-65 - PubMed
    1. Psychopharmacologia. 1974;40(2):109-20 - PubMed
    1. J Pharmacol Exp Ther. 1976 Jul;198(1):66-82 - PubMed
    1. Arch Int Pharmacodyn Ther. 1974 Dec;212(2):199-204 - PubMed

MeSH terms

LinkOut - more resources